37 results
Page 2 of 2
6-K
EX-99.1
g7l70gpe
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
8d8199u vxqn
7 Feb 22
Current report (foreign)
2:40pm
6-K
EX-99.1
9ava5t4wcalvnb
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.1
ximfz
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.2
pl2x4n37vq
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
ubdtytzhvcgn
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.2
ao750xwdsq
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.1
hhqq8q2ki gfjk
11 Jun 19
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
6:05am
20-F
1wlkty
25 Mar 16
Annual report (foreign)
12:00am
DRS
EX-10
ur40rjuj92p k373z9l
6 Feb 15
Draft registration statement
12:00am
DRS
hwc0mc vf
6 Feb 15
Draft registration statement
12:00am